Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina Chiaretti

Showing results (111-120 of 172) with videos related to

Pageof 18
Sort By:
American Journal of Hematology|May 28, 2021
Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996Alfonso Piciocchi, Monica Messina, Loredana Elia, et al.
Leukemia|January 22, 2026
Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemiaMichela Ansuinelli, Nadia Peragine, Maria Stefania De Propris, et al.
Blood|February 20, 2014
Genetic lesions associated with chronic lymphocytic leukemia chemo-refractorinessMonica Messina, Ilaria Del Giudice, Hossein Khiabanian, et al.
Haematologica|August 13, 2016
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 studySabina Chiaretti, Antonella Vitale, Marco Vignetti, et al.
British Journal of Haematology|December 14, 2011
Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genesIlaria Del Giudice, Monica Messina, Sabina Chiaretti, et al.
Leukemia Research|January 13, 2016
CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalitiesSabina Chiaretti, Fulvia Brugnoletti, Monica Messina, et al.
Leukemia & Lymphoma|July 13, 2019
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocolRenato Bassan, Monica Fumagalli, Sabina Chiaretti, et al.
British Journal of Haematology|November 25, 2015
Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartmentsIlaria Del Giudice, Marilisa Marinelli, Jiguang Wang, et al.
Panminerva Medica|June 28, 2022
Acute leukemia diagnosis during the COVID-19 pandemicLuca Guarnera, Elisa Buzzatti, Francesco Marchesi, et al.
American Journal of Hematology|December 7, 2020
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trialAnna Maria Testi, Martina Canichella, Antonella Vitale, et al.
Pageof 18

Showing results (111-120 of 172) with videos related to

Sort By:
Pageof 18
American Journal of Hematology|May 28, 2021
Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996Alfonso Piciocchi, Monica Messina, Loredana Elia, et al.
Leukemia|January 22, 2026
Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemiaMichela Ansuinelli, Nadia Peragine, Maria Stefania De Propris, et al.
Blood|February 20, 2014
Genetic lesions associated with chronic lymphocytic leukemia chemo-refractorinessMonica Messina, Ilaria Del Giudice, Hossein Khiabanian, et al.
Haematologica|August 13, 2016
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 studySabina Chiaretti, Antonella Vitale, Marco Vignetti, et al.
British Journal of Haematology|December 14, 2011
Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genesIlaria Del Giudice, Monica Messina, Sabina Chiaretti, et al.
Leukemia Research|January 13, 2016
CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalitiesSabina Chiaretti, Fulvia Brugnoletti, Monica Messina, et al.
Leukemia & Lymphoma|July 13, 2019
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocolRenato Bassan, Monica Fumagalli, Sabina Chiaretti, et al.
British Journal of Haematology|November 25, 2015
Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartmentsIlaria Del Giudice, Marilisa Marinelli, Jiguang Wang, et al.
Panminerva Medica|June 28, 2022
Acute leukemia diagnosis during the COVID-19 pandemicLuca Guarnera, Elisa Buzzatti, Francesco Marchesi, et al.
American Journal of Hematology|December 7, 2020
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trialAnna Maria Testi, Martina Canichella, Antonella Vitale, et al.
Pageof 18